Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
4DMedicalFDMDF 53 Future 3-5Y EPS without NRI Growth Rate is 46.33 as of Aug. 22, 2026. GuruFocus rates FDMDF with a GF Score™ of 53/100 and a GF Value™ of $1.14 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 279 Medical Devices & Instruments companies, 4DMedical ranks better than 84.59% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
As of today, 4DMedical's Future 3-5Y EPS without NRI Growth Rate is 46.33.
4DMedical (OTCPK:FDMDF) Future 3-5Y EPS without NRI Growth Rate Explanation
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
4DMedical Future 3-5Y EPS without NRI Growth Rate Related Terms
FDMDF vs ABT, SYK, MDT: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Medical Devices subindustry, 4DMedical's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4DMedical Future 3-5Y EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where 4DMedical's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 46.33 mean?
4DMedical (FDMDF) has a Future 3-5Y EPS without NRI Growth Rate of 46.33 as of Aug. 22, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for 4DMedical and its competitors. According to the industry distribution chart, 4DMedical ranks #43 out of 279 companies in the Medical Devices & Instruments industry, placing it in the top 15.4%.
Is 4DMedical's Future 3-5Y EPS without NRI Growth Rate too high?
4DMedical's current Future 3-5Y EPS without NRI Growth Rate is 46.33. The Medical Devices & Instruments industry median Future 3-5Y EPS without NRI Growth Rate is 20.97. 4DMedical's value of 46.33 is 120.9% above this industry median. Based on the distribution chart, 4DMedical ranks #43 out of 279 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, 4DMedical has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's Future 3-5Y EPS without NRI Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 4DMedical ranks #43 out of 279 companies for Future 3-5Y EPS without NRI Growth Rate. This places 4DMedical in the top 15% of its industry — outperforming the majority of peers. The industry median Future 3-5Y EPS without NRI Growth Rate is 20.97. 4DMedical's value of 46.33 is 120.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median Future 3-5Y EPS without NRI Growth Rate among Medical Devices & Instruments companies is 20.97, based on 279 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 4DMedical's current Future 3-5Y EPS without NRI Growth Rate of 46.33 is 120.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for 4DMedical and its competitors. For the Medical Devices & Instruments industry, the median Future 3-5Y EPS without NRI Growth Rate is 20.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4DMedical's current Future 3-5Y EPS without NRI Growth Rate is 46.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (FDMDF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.14, compared to a current price of $2.95 — trading 158.8% above its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 46.33 and 120.9% above the Medical Devices & Instruments industry median of 20.97. 4DMedical's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For 4DMedical (FDMDF), the current Future 3-5Y EPS without NRI Growth Rate is 46.33 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 4DMedical (FDMDF) Overvalued in 2026?
Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued.
The current stock price of $2.95 is trading 158.8% above its estimated GF Value™ of $1.14.
GuruFocus considers 4DMedical to be Significantly Overvalued.
Key valuation signals for FDMDF:
Future 3-5Y EPS without NRI Growth Rate: 46.33
GF Value™: $1.14 vs. price of $2.95 (158.8% above fair value)
Industry Position: 120.9% above the Medical Devices & Instruments median (#43 of 279)
No single metric tells the full story. See the FDMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
53GF Score
Get the complete analysis for FDMDF
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FDMDF has been successfully added to your 
